Reversibility of increased intrathoracic gas volume and decreased compliance in infants with pulmonary hyperperfusion and hypertension after repair of congenital heart disease

M. Henschen, J. M. Spolnik, M. Albiez, C. Schlensak, D. Kececioglu, S. Dittrich (Freiburg, Germany)

Source: Annual Congress 2005 - Clinical application of paediatric lung function testing
Session: Clinical application of paediatric lung function testing
Session type: Poster Discussion
Number: 4283
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Henschen, J. M. Spolnik, M. Albiez, C. Schlensak, D. Kececioglu, S. Dittrich (Freiburg, Germany). Reversibility of increased intrathoracic gas volume and decreased compliance in infants with pulmonary hyperperfusion and hypertension after repair of congenital heart disease. Eur Respir J 2005; 26: Suppl. 49, 4283

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009



Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010



Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 422-430
Year: 2015



Usefulness of differential blood gas exchange assessment in patients with severe pulmonary arterial hypertension (PAH) associated to congenital heart disease (CHD)
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005

Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

Double combination therapy in patients with pulmonary arterial hypertension associated with congenital heart defects
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Spontaneous haemodynamic variability during right heart catetherisation in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Hemodynamic assessment of pulmonary hypertension in grown-up congenital heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011



Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Pulmonary vascular distensibility in pulmonary hypertension due to left heart disease
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018

Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Intracardiac shunt measurement by MRI in patients with pulmonary arterial hypertension caused by a congenital septum defect
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005

Nebulised Iloprost for pulmonary arterial hypertension associated with congenital heart disease: one centre's experience
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001

The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012